Total MRI Imaging Helps Detect Prostate Cancer
By MedImaging International staff writers Posted on 03 Nov 2015 |
Image: Dr. Jorge Fernández de la Torre and the MRI at San José Tec (Photo courtesy of Siemens).
A new approach to magnetic resonance imaging (MRI) can assist in the detection of prostate cancer without using an invasive endorectal probe.
Developed at Hospital San José Tec (Monterrey, Mexico), the new approach replaces the standard endorectal MRI coil with a surface coil placed on the pelvis, like a collar. By using only external body coils, the technique offers more comfort to the patient, with a reliability that appears to be comparable to the invasive approach. The new approach is available due to the high element density of Siemens Healthcare (Erlangen, Germany) total imaging matrix (TIM) technology, which provides excellent signal-to-noise ratio (SNR).
TIM represents a revolutionary addition to the traditional MRI process, using as many as 76 seamlessly integrated coil elements and 32 independent receiver channels to create a whole-body imaging matrix, supporting a total field of view of 205 cm. And while conventional metastases evaluation requires changing coils and repositioning the patient for each anatomical area of interest—head, thoracic, abdominal, pelvis, etc.—TIM simplifies the process and shortens examination times. Both the matrix coils and the patient need only be positioned once for all desired exams, as multiple channels allow a unique and almost unlimited scanning flexibility.
“The shame experienced with a rectal examination of the prostate is particularly high in the Mexican and Latin American cultures. This holds true for a simple digital prostate exam as well as for more advanced diagnostic procedures like magnetic resonance imaging with the aid of a rectal probe,” said Jorge Fernández de la Torre, MD, chief radiologist at Hospital San José Tec. “My mother died of cancer shortly after I started college. Watching her suffer really stirred up my emotions. I would like to save other people from a fate like hers.”
The American Cancer Society (ACS) recommends that a discussion about screening should take place in men 50 years old who are at average risk of prostate cancer and are expected to live at least 10 more years; men aged 45 at high risk of developing prostate cancer, including African-Americans and men who have a first-degree relative diagnosed with prostate cancer at an early age (younger than age 65); and men aged 40 with more than one first-degree relative who had prostate cancer at an early age. Those screened should be tested with the prostate-specific antigen (PSA) blood test. A digital rectal exam (DRE) may also be done as a part of screening.
Related Links:
Hospital San José Tec
Siemens Healthcare
Developed at Hospital San José Tec (Monterrey, Mexico), the new approach replaces the standard endorectal MRI coil with a surface coil placed on the pelvis, like a collar. By using only external body coils, the technique offers more comfort to the patient, with a reliability that appears to be comparable to the invasive approach. The new approach is available due to the high element density of Siemens Healthcare (Erlangen, Germany) total imaging matrix (TIM) technology, which provides excellent signal-to-noise ratio (SNR).
TIM represents a revolutionary addition to the traditional MRI process, using as many as 76 seamlessly integrated coil elements and 32 independent receiver channels to create a whole-body imaging matrix, supporting a total field of view of 205 cm. And while conventional metastases evaluation requires changing coils and repositioning the patient for each anatomical area of interest—head, thoracic, abdominal, pelvis, etc.—TIM simplifies the process and shortens examination times. Both the matrix coils and the patient need only be positioned once for all desired exams, as multiple channels allow a unique and almost unlimited scanning flexibility.
“The shame experienced with a rectal examination of the prostate is particularly high in the Mexican and Latin American cultures. This holds true for a simple digital prostate exam as well as for more advanced diagnostic procedures like magnetic resonance imaging with the aid of a rectal probe,” said Jorge Fernández de la Torre, MD, chief radiologist at Hospital San José Tec. “My mother died of cancer shortly after I started college. Watching her suffer really stirred up my emotions. I would like to save other people from a fate like hers.”
The American Cancer Society (ACS) recommends that a discussion about screening should take place in men 50 years old who are at average risk of prostate cancer and are expected to live at least 10 more years; men aged 45 at high risk of developing prostate cancer, including African-Americans and men who have a first-degree relative diagnosed with prostate cancer at an early age (younger than age 65); and men aged 40 with more than one first-degree relative who had prostate cancer at an early age. Those screened should be tested with the prostate-specific antigen (PSA) blood test. A digital rectal exam (DRE) may also be done as a part of screening.
Related Links:
Hospital San José Tec
Siemens Healthcare
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer